van den Berg E - Search Results

1

Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group.

Brekke HR, Ribeiro FR, Kolberg M, Agesen TH, Lind GE, Eknaes M, Hall KS, Bjerkehagen B, van den Berg E, Teixeira MR, Mandahl N, Smeland S, Mertens F, Skotheim RI, Lothe RA. Brekke HR, et al. Among authors: van den berg e. J Clin Oncol. 2010 Mar 20;28(9):1573-82. doi: 10.1200/JCO.2009.24.8989. Epub 2010 Feb 16. J Clin Oncol. 2010. PMID: 20159821

2

Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.

Agesen TH, Flørenes VA, Molenaar WM, Lind GE, Berner JM, Plaat BE, Komdeur R, Myklebost O, van den Berg E, Lothe RA. Agesen TH, et al. Among authors: van den berg e. J Neuropathol Exp Neurol. 2005 Jan;64(1):74-81. doi: 10.1093/jnen/64.1.74. J Neuropathol Exp Neurol. 2005. PMID: 15715087

3

Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.

Danielsen SA, Lind GE, Kolberg M, Høland M, Bjerkehagen B, Sundby Hall K, van den Berg E, Mertens F, Smeland S, Picci P, Lothe RA. Danielsen SA, et al. Among authors: van den berg e. Neuro Oncol. 2015 Jan;17(1):63-9. doi: 10.1093/neuonc/nou140. Epub 2014 Jul 19. Neuro Oncol. 2015. PMID: 25038505 Free PMC article.

4

Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53.

Høland M, Kolberg M, Danielsen SA, Bjerkehagen B, Eilertsen IA, Hektoen M, Mandahl N, van den Berg E, Smeland S, Mertens F, Sundby Hall K, Picci P, Sveen A, Lothe RA. Høland M, et al. Among authors: van den berg e. Mod Pathol. 2018 Nov;31(11):1694-1707. doi: 10.1038/s41379-018-0074-y. Epub 2018 Jun 26. Mod Pathol. 2018. PMID: 29946184 Free article.

5

Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours.

Bottillo I, Ahlquist T, Brekke H, Danielsen SA, van den Berg E, Mertens F, Lothe RA, Dallapiccola B. Bottillo I, et al. Among authors: van den berg e. J Pathol. 2009 Apr;217(5):693-701. doi: 10.1002/path.2494. J Pathol. 2009. PMID: 19142971

6

Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors.

Håvik AB, Lind GE, Honne H, Meling TR, Scheie D, Hall KS, van den Berg E, Mertens F, Picci P, Lothe RA, Heim S, Brandal P. Håvik AB, et al. Among authors: van den berg e. Neuro Oncol. 2014 Jan;16(2):320-2. doi: 10.1093/neuonc/not230. Epub 2013 Dec 4. Neuro Oncol. 2014. PMID: 24311631 Free PMC article. No abstract available.

7

Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.

Harrison CJ, Hills RK, Moorman AV, Grimwade DJ, Hann I, Webb DK, Wheatley K, de Graaf SS, van den Berg E, Burnett AK, Gibson BE. Harrison CJ, et al. Among authors: van den berg e. J Clin Oncol. 2010 Jun 1;28(16):2674-81. doi: 10.1200/JCO.2009.24.8997. Epub 2010 May 3. J Clin Oncol. 2010. PMID: 20439644

8

Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma.

Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van den Berg E, Myklebost O, Bridge J, van Kessel AG, Suijkerbuijk R. Simons A, et al. Among authors: van de zande g, van den berg e, van kessel ag. Cancer Genet Cytogenet. 2000 Apr 15;118(2):89-98. doi: 10.1016/s0165-4608(99)00178-8. Cancer Genet Cytogenet. 2000. PMID: 10748288

9

Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas.

Plaat BE, Molenaar WM, Mastik MF, Hoekstra HJ, te Meerman GJ, van den Berg E. Plaat BE, et al. Among authors: van den berg e. Int J Cancer. 1999 Oct 8;83(2):171-8. doi: 10.1002/(sici)1097-0215(19991008)83:2<171::aid-ijc5>3.0.co;2-s. Int J Cancer. 1999. PMID: 10471523 Free article.

10

Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.

Plaat BE, Hollema H, Molenaar WM, Torn Broers GH, Pijpe J, Mastik MF, Hoekstra HJ, van den Berg E, Scheper RJ, van der Graaf WT. Plaat BE, et al. Among authors: van der graaf wt, van den berg e. J Clin Oncol. 2000 Sep 15;18(18):3211-20. doi: 10.1200/JCO.2000.18.18.3211. J Clin Oncol. 2000. PMID: 10986053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

514 results

Search Page